MIRCADE team collaboration with DeepLife

Team 6 MIRCADE of our BRIC unit and the Paris-based biotech company DeepLife have signed a research collaboration contract with the support of Inserm Transfert, a private subsidiary of Inserm
The project aims to harness the power of omics data and perform an in-depth analysis of the molecular landscape of hepatoblastoma, the leading childhood liver cancer, using bioinformatics and artificial intelligence approaches. The aim of this collaborative project is to discover new drug combinations to combat this pediatric cancer, and in particular to treat relapsed patients more effectively.